INTRODUCTION: Patients with aneurysmal subarachnoid hemorrhage (SAH) frequently undergo multiple angiographic studies within a 48-h period. We sought to evaluate the impact of these repeated contrast loads on renal function. METHODS: We reviewed the records of a consecutive series of 104 patients with aneurysmal subarachnoid hemorrhage, most of whom underwent at least an initial CT angiogram and digital subtraction angiography. Six patients had baseline renal disease. Initial creatinine levels were compared to maximum levels over a subsequent 48-h period after their last angiographic study. We defined contrast-induced nephropathy (CIN) as an increase in creatinine of at least 0.3 from baseline. RESULTS: The mean change in creatinine following treatment was 0.05 ± 0.23, with three patients developing CIN (2.9%). In 2 cases of CIN, the creatinine increase was inconsequential (0.39 and 0.44). All patients with CIN had an early return of their creatinine to baseline; none required dialysis or suffered permanent sequelae as a result of these creatinine increases. There was no statistically significant difference in the rate of CIN in patients treated with microsurgical clipping (n = 85) as compared to those who underwent coiling (n = 19). CONCLUSION: Our results underscore the relative safety of the usage of multiple angiographic studies performed in patients with aneurysmal SAH, particularly in patients without baseline renal disease.
INTRODUCTION:Patients with aneurysmal subarachnoid hemorrhage (SAH) frequently undergo multiple angiographic studies within a 48-h period. We sought to evaluate the impact of these repeated contrast loads on renal function. METHODS: We reviewed the records of a consecutive series of 104 patients with aneurysmal subarachnoid hemorrhage, most of whom underwent at least an initial CT angiogram and digital subtraction angiography. Six patients had baseline renal disease. Initial creatinine levels were compared to maximum levels over a subsequent 48-h period after their last angiographic study. We defined contrast-induced nephropathy (CIN) as an increase in creatinine of at least 0.3 from baseline. RESULTS: The mean change in creatinine following treatment was 0.05 ± 0.23, with three patients developing CIN (2.9%). In 2 cases of CIN, the creatinine increase was inconsequential (0.39 and 0.44). All patients with CIN had an early return of their creatinine to baseline; none required dialysis or suffered permanent sequelae as a result of these creatinine increases. There was no statistically significant difference in the rate of CIN in patients treated with microsurgical clipping (n = 85) as compared to those who underwent coiling (n = 19). CONCLUSION: Our results underscore the relative safety of the usage of multiple angiographic studies performed in patients with aneurysmalSAH, particularly in patients without baseline renal disease.
Authors: Michael Moussouttas; Edwin W Lai; John Khoury; Thanh T Huynh; Keith Dombrowski; Karel Pacak Journal: Neurocrit Care Date: 2012-06 Impact factor: 3.210
Authors: Henriëtte E Westerlaan; J M C van Dijk; M J van Dijk; Marijke C Jansen-van der Weide; Jan Cees de Groot; Rob J M Groen; Jan Jakob A Mooij; Matthijs Oudkerk Journal: Radiology Date: 2010-10-08 Impact factor: 11.105
Authors: Jefferson T Miley; Robert A Taylor; Vallabh Janardhan; Ramachandra Tummala; Giuseppe Lanzino; Adnan I Qureshi Journal: Neurocrit Care Date: 2008 Impact factor: 3.210
Authors: Brian L Hoh; Arnold C Cheung; James D Rabinov; Johnny C Pryor; Bob S Carter; Christopher S Ogilvy Journal: Neurosurgery Date: 2004-06 Impact factor: 4.654
Authors: J J Hopyan; D J Gladstone; G Mallia; J Schiff; A J Fox; S P Symons; B H Buck; S E Black; R I Aviv Journal: AJNR Am J Neuroradiol Date: 2008-08-21 Impact factor: 3.825
Authors: Alexandra Oleinik; Javier M Romero; Kristin Schwab; Michael H Lev; Nupur Jhawar; Josser E Delgado Almandoz; Eric E Smith; Steven M Greenberg; Jonathan Rosand; Joshua N Goldstein Journal: Stroke Date: 2009-05-21 Impact factor: 7.914
Authors: Martin Kieninger; Daniel Unbekannt; André Schneiker; Barbara Sinner; Sylvia Bele; Christopher Prasser Journal: Neurocrit Care Date: 2017-02 Impact factor: 3.210
Authors: Avinash B Kumar; Yaping Shi; Matthew S Shotwell; Justin Richards; Jesse M Ehrenfeld Journal: Neurocrit Care Date: 2015-04 Impact factor: 3.210
Authors: Hyun Goo Lee; Won Ki Kim; Je Young Yeon; Jong Soo Kim; Keon Ha Kim; Pyoung Jeon; Seung Chyul Hong Journal: Yonsei Med J Date: 2018-01 Impact factor: 2.759